Literature DB >> 20537867

Re-epithelialization from human skin explant cultures is promoted by ligand-activated HER3 receptor.

Sofi Forsberg1, Ola Rollman.   

Abstract

BACKGROUND: Ligand-stimulated epidermal growth factor receptor (EGFR/HER1) plays a fundamental role in skin biology as potent transducer of mitotic and anti-apoptotic stimuli in keratinocytes. In human epidermis, at least two additional EGFR family members--HER2 and HER3--are expressed but their biological functions in normal and diseased human skin remain obscure.
OBJECTIVE: Here, we studied the expression and biological impact of HER3 in regenerating human epidermis formed from skin explants adhered to acellular dermis.
METHODS: Neoepidermal HER3 expression was examined by quantitative real-time reverse transcriptase polymerase chain reaction, immunohistochemistry and Western blot analysis. The dynamic effect of HER3 receptor stimulation by recombinant heregulin (HRG)-beta1 was assessed by fluorescence imaging of re-epithelialization.
RESULTS: In the neoepidermis, HER3 mRNA and protein were detected with activated receptors being immunolocalized at basal and low suprabasal levels. Exogenous HRG-beta1 at 10-20 ng/ml increased the outgrowth rate corresponding to approximately 30% the response of exogenous EGF. The growth-promoting effect of HRG-beta1 was associated with enhanced HER3 phosphorylation, keratinocyte proliferation and thickening of viable neoepidermis whereas blockade of ligand-binding to HER3 delayed the outgrowth process and inhibited both constitutive and ligand-induced HER3 phosphorylation. HER2 antagonism using an anti-dimerization antibody, pertuzumab, impeded the re-epithelialization rate. In addition, a selective HER2 kinase inhibitor, CP654577, downregulated phospho-HER3 expression suggesting that transactivation of kinase-deficient HER3 was accomplished through dimerization with HER2.
CONCLUSION: The study emphasizes the central role of EGFR in epidermal renewal and demonstrates that HRG-activated HER3 contributes to the outgrowth process of epidermis in vitro. Copyright (c) 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537867     DOI: 10.1016/j.jdermsci.2010.03.017

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  4 in total

1.  Reduction of the relative centrifugal force influences cell number and growth factor release within injectable PRF-based matrices.

Authors:  Simon Wend; Alica Kubesch; Anna Orlowska; Sarah Al-Maawi; Niklas Zender; Andre Dias; Richard J Miron; Robert Sader; Patrick Booms; C James Kirkpatrick; Joseph Choukroun; Shahram Ghanaati
Journal:  J Mater Sci Mater Med       Date:  2017-10-25       Impact factor: 3.896

2.  ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis.

Authors:  Maik Dahlhoff; Matthias Schäfer; Sukalp Muzumdar; Christian Rose; Marlon R Schneider
Journal:  Mol Oncol       Date:  2015-07-03       Impact factor: 6.603

3.  Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy.

Authors:  Joanne Mortimer; Jae Jung; Yuan Yuan; Laura Kruper; Daphne Stewart; Samuel Chung; Kim Wai Yu; Mary Mendelsohn; Massimo D'Apuzzo; Bernard Tegtmeier; Sanjeet Dadwal
Journal:  Breast Cancer Res Treat       Date:  2014-11-11       Impact factor: 4.872

Review 4.  Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Front Med (Lausanne)       Date:  2017-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.